Related Experiment Videos
Protein immobilization in crosslinked alginate microparticles.
G Coppi1, V Iannuccelli, E Leo
1Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia, Modena, Italy. coppi.gilberto@unimo.it
Journal of Microencapsulation
|January 29, 2002
Summary
This study developed alginate microsystems to protect protein drugs during oral delivery. The microsystems demonstrated stability and controlled release, showing potential for improved drug bioavailability.
Area of Science:
- Biomaterials Science
- Pharmaceutical Technology
- Drug Delivery Systems
Background:
- Oral delivery of peptide and protein drugs is challenging due to gastro-intestinal degradation.
- Effective drug carriers are needed to protect sensitive biomolecules and target absorption sites.
Purpose of the Study:
- To develop and evaluate alginate microsystems for oral protein drug delivery.
- To investigate the impact of formulation variables (Na-A/BSA ratio, crosslinking pH) on microsystem properties.
- To assess protein stability and release characteristics within the microsystem.
Main Methods:
- Spray-drying technique for alginate microsystem fabrication.
- Crosslinking with Ca2+ and chitosan (CS) for enhanced stability.
- Evaluation of microsystem morphology, BSA loading, encapsulation efficiency, and in vitro release.
- Polyacrylamide gel electrophoresis (PAGE) for protein stability assessment.
Main Results:
- Microsystem characteristics were largely unaffected by formulation variables.
- Higher BSA loading was achieved at pH values below the protein's isoelectric point due to electrostatic interactions.
- Maximum encapsulation efficiency correlated with the highest sodium alginate (Na-A) to bovine serum albumin (BSA) ratio.
- Protein release was primarily governed by the pH-dependent properties of the alginate material, not preparative variables.
- PAGE confirmed protein stability throughout preparation and simulated gastro-intestinal conditions.
Conclusions:
- Alginate microsystems offer a promising approach for oral protein drug delivery.
- Formulation parameters, particularly pH and polymer-to-protein ratio, influence encapsulation efficiency.
- The developed microsystems provide adequate protection and controlled release of model protein (BSA).
- The study highlights the potential of these microsystems for enhancing oral bioavailability of protein therapeutics.